Inventor · disambiguated record
Johnny Uy
Also filed as: UY JOHNNY
23 granted patents·8 pending applications·272 citations·filing 2008–2024
95Inventor score
Top patents by PatentIndex Score
31 records- 0198US10793547B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Oct 6, 2020·24 cites·21 claims
- 0297US11453655B2Modulator of the cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2020·Granted Sep 27, 2022·8 cites·8 claims
- 0397US10758534B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Granted Sep 1, 2020·13 cites·38 claims
- 0497US10258624B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·32 cites·47 claims
- 0597US9782408B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·33 cites·84 claims
- 0696US11426407B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Aug 30, 2022·6 cites·47 claims
- 0796US10570115B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2017·Granted Feb 25, 2020·23 cites·18 claims
- 0895US12421251B2Cystic fibrosis transmembrane conductance regulator modulating agentsVERTEX PHARMA·Filed 2020·Granted Sep 23, 2025·5 cites·25 claims
- 0995US11066417B2Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2019·Granted Jul 20, 2021·13 cites·47 claims
- 1094US11866450B2Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·3 cites·41 claims
- 1194US8158647B2Substituted pyrrolopyridines and pyrazolopyridines as kinase modulatorsBLANEY JEFFREY M·Filed 2008·Granted Apr 17, 2012·93 cites·35 claims
- 1293US12168009B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Granted Dec 17, 2024·1 cites·46 claims
- 1392US11186566B2Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2019·Granted Nov 30, 2021·10 cites·10 claims
- 1491US10738030B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Aug 11, 2020·6 cites·48 claims
- 1588US2025205232A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1681US12384762B2Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2022·Granted Aug 12, 2025·0 cites·3 claims
- 1778US2024368189A1Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the ModulatorsVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 1877US8202891B2Quaternary ammonium compounds useful as muscarinic receptor antagonistsHUSFELD CRAIG·Filed 2008·Granted Jun 19, 2012·2 cites·16 claims
- 1971US2022306606A1Modulator of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2064US2025340574A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2163US9216971B2Quaternary ammonium compounds useful as muscarinic receptor antagonistsHUSFELD CRAIG·Filed 2014·Granted Dec 22, 2015·0 cites·6 claims
- 2260US8815907B2Quaternary ammonium compounds useful as muscarinic receptor antagonistsHUSFELD CRAIG·Filed 2013·Granted Aug 26, 2014·0 cites·16 claims
- 2357US8492407B2Quaternary ammonium compounds useful as muscarinic receptor antagonistsHUSFELD CRAIG·Filed 2012·Granted Jul 23, 2013·0 cites·17 claims
- 2456US2023382924A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2556US2023382925A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2656US2024150377A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 2750US2022313698A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Application pending·0 cites
- 2846US10233191B2Fused piperidine amides as modulators of ion channelsVERTEX PHARMA·Filed 2014·Granted Mar 19, 2019·0 cites·32 claims
- 2942US9403839B2Pyran-spirocyclic piperidine amides as modulators of ion channelsVERTEX PHARMA·Filed 2013·Granted Aug 2, 2016·0 cites·23 claims
- 3041US10385070B2Chroman-spirocyclic piperidine amides as modulators of ion channelsHADIDA RUAH SARA SABINA·Filed 2012·Granted Aug 20, 2019·0 cites·43 claims
- 3141US9365588B2Benzoxazines as modulators of ion channelsHADIDA-RUAH SARA SABINA·Filed 2012·Granted Jun 14, 2016·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Johnny Uy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →